Clinical efficacy of CO(2) laser combined with 5-aminolevulinic acid photodynamic therapy in treating periungual and plantar warts

二氧化碳激光联合5-氨基乙酰丙酸光动力疗法治疗甲周疣和跖疣的临床疗效

阅读:1

Abstract

OBJECTIVE: To analyze the clinical application value of CO(2) laser combined with 5-aminolevulinic acid photodynamic therapy for periungual and plantar warts. METHODS: Data from patients with periungual and plantar warts treated at Qingpu branch of Zhongshan Hospital, Fudan University between August 2022 and January 2024 were retrospectively analyzed. After screening based on inclusion and exclusion criteria, 96 patients were included and categorized into two groups according to their treatment regimens: a combination group (n=50, receiving CO(2) laser therapy and 5-aminolevulinic acid photodynamic therapy) and a control group (n=46, undergoing CO(2) laser treatment alone). The two groups were compared in terms of wart scores before and after treatment, clinical efficacy, recurrence rates during follow-up, and incidence of adverse reactions. RESULTS: During the 4th, 6th, and 8th weeks of treatment, the wart scores of patients in the combination group were significantly lower than those of the control group (P<0.05), and at these intervals, the overall treatment efficacy in the combination group was significantly higher than that of the control group (P<0.05). At 3-month follow-up, the recurrence rate in the combination group (2.00%) was lower than that in the control group (10.87%) (P<0.05). At the 2nd, 4th, 6th, and 8th weeks of treatment, the Visual Analog Scale scores in the combination group were significantly reduced compared to the control group (P<0.05). No significant difference was found in the incidence of adverse reactions between the two groups during follow-up (P>0.05). CONCLUSION: The application of CO(2) laser therapy combined with 5-aminolevulinic acid photodynamic therapy is effective for patients suffering from periungual and plantar warts, and this combination enhances clinical outcome, mitigates pain, and reduces short-term recurrence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。